Patents Assigned to Merck Patent GmnH
  • Cladribine regimen for treating progressive forms of Multiple Sclerosis
    Publication number: 20210169912
    Abstract: Specific oral dosings, specific oral dosage forms, and/or specific oral dose regimens including Cladribine can be effective for the treatment of progressive forms of Multiple Sclerosis, especially Primary Progressive Multiple Sclerosis and/or Secondary Progressive Multiple Sclerosis. Methods of treatment can be based on specific oral dosings, specific oral dosage forms, and/or specific oral dose regimens including Cladribine.
    Type: Application
    Filed: October 23, 2020
    Publication date: June 10, 2021
    Applicant: Merck Patent GmnH
    Inventors: Fernando Dangond, Matthias Dotzauer
  • MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES
    Publication number: 20130240796
    Abstract: The present invention relates to compounds of the formula (1) and formula (2) which are suitable for use in electronic devices, in particular in organic electroluminescent devices.
    Type: Application
    Filed: October 27, 2011
    Publication date: September 19, 2013
    Applicant: Merck Patent GmnH
    Inventors: Amir Hossain Parham, Christof Pflumm, Rémi Manouk Anémian, Hubert Spreitzer